Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
The deal, backed by healthcare investor ARCHIMED, signals a major push to accelerate connected, patient-centered cardiac care worldwide
Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities
The Puducherry facility, dedicated to Ibuprofen and its derivatives, is equipped with advanced infrastructure to serve both domestic and international markets
The agreement could rise to $900 million if key commercial milestones are met
The medtech firm strengthens its full-stack remote cardiac monitoring platform, achieves 11x revenue growth, and advances its global expansion plans
Acquisition enhances integrated pharmacovigilance platform, combining AI, automation, and services to improve compliance, efficiency, and end-to-end clinical safety operations
Backed by ARCHIMED, the deal strengthens connected cardiac diagnostics with integrated Holter, ABPM, and telemedicine solutions
Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
EUDRAGIT polymers remain a cornerstone technology in oral drug delivery
Subscribe To Our Newsletter & Stay Updated